Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Eye polymers are licensed
July 17, 2006
| A version of this story appeared in
Volume 84, Issue 29
Seal Sands Chemicals, part of the newly formed Vertellus Specialties (see page 8), has licensed biocompatible polymer technology from Biocompatibles International. According to Seal Sands, the polymers are based on phosphorylcholine derivatives and are used primarily in contact lenses, where they inhibit protein deposition and reduce eye irritation. Neil McLoughlin, vice president of Vertellus' health and specialty products unit in Europe, notes that Seal Sands has been producing the polymers for Biocompatibles for a number of years.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter